Why the study?
Does the HeartMate II continuous-flow left ventricular assist device improve renal and hepatic function in advanced heart failure patients bridged to transplantation?
Does the HeartMate II continuous-flow left ventricular assist device improve renal and hepatic function in advanced heart failure patients bridged to transplantation?
Continuous-flow LVAD support with HeartMate II improves renal and hepatic function in advanced heart failure patients awaiting transplant over 6 months.
Answers are grounded in this paper and cite their sources.
May support end-organ recovery with HeartMate II in bridge-to-transplant; leaves open need for randomized confirmation of long-term pulsatility effects.
The HeartMate II continuous-flow left ventricular assist device improves renal and hepatic function in advanced heart failure patients who are being bridged to transplantation, without evidence of detrimental effects from reduced pulsatility over a 6-month time period.
No takes yet. Share an insight, caveat, or question.
Russell et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: